Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial

Behringer, KKBehringerThielen, IIThielenMueller, HHMuellerGoergen, HHGoergenEibl, A DA DEiblRosenbrock, JJRosenbrockHalbsguth, TTHalbsguthEichenauer, D AD AEichenauerFuchs, MMFuchsReiners, K SK SReinersRenno, J HJ HRennovan der Ven, KKvan der VenKuehr, MMKuehrvon Wolff, MichaelMichaelvon WolffDiehl, VVDiehlEngert, AAEngertBorchmann, PPBorchmann2024-10-132024-10-132012https://boris-portal.unibe.ch/handle/20.500.12422/90485In the HD14 trial, 2×BEACOPPescalated+2×ABVD (2+2) has improved the primary outcome. Compared with 4×ABVD, this benefit might be compromised by more infertility in women. Therefore, we analyzed gonadal function and fertility.enFertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trialarticle10.7892/boris.164712222845100030613520002610.1093/annonc/mdr575